Journal of Commercial Biotechnology logo Palgrave Macmillan logo

Publisher: Palgrave Macmillan

Volume 9, Number 3, 1 March 2003
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

< previous issue | next issue > | all issues

Editorial: Best practices in communicating biotechnology
pp. 187-188(2)
Author: Russo, Anthony J

Comment: The UK Government's strategic approach to the biotechnology industry
pp. 189-191(3)
Author: Sainsbury, Lord

The ethics of patenting DNA
pp. 192-198(7)
Author: Reiss, Michael J

Recent developments in US law: Remedies and damages for improper patent listings in the FDA's Orange Book
pp. 199-208(10)
Author: Brown, Daniel G

Spinning off, cashing up and branching out: Commercialisation considerations for bioentrepreneurs in Australasia
pp. 209-218(10)
Authors: Wells, Nick; Coady, Brendan; Inge, Josephine

Biotechnology education in Europe
pp. 219-230(12)
Author: Moses, Vivian

Database protection in the UK and the USA: What, if any, protection might those who work so hard receive?
pp. 231-241(11)
Authors: Nott, Robin M C; Huntington, R Danny; Dunston, Erin M

Early stage and seed financing for biotechnology start-ups: A UK perspective
pp. 242-248(7)
Author: Whitehead, George

Legal issues in bioinformatics
pp. 249-265(17)
Author: McCubbin, Caroline

Legal and regulatory update
pp. 266-276(11)

EU Financial accounts reports
pp. 277-280(4)
Author: Citron, David

< previous issue | next issue > | all issues

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A